DekaBank Deutsche Girozentrale’s Aurinia Pharmaceuticals AUPH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,480	Closed	-$60K	–	1399
2025 Q1	$60K	Buy	+7,480	New	+$60.6K	﹤0.01%	1276
2024 Q2	–	Sell	-7,480	Closed	-$36K	–	1456
2024 Q1	$36K	Sell	7,480 -11,608	-61%	-$78.7K	﹤0.01%	1394
2023 Q4	$172K	Buy	19,088 +10,640	+126%	+$87.6K	﹤0.01%	1237
2023 Q3	$65K	Buy	+8,448	New	+$82.6K	﹤0.01%	1363
2022 Q4	–	Sell	-50,200	Closed	-$362K	–	1343
2022 Q3	$362K	Hold	50,200	–	–	﹤0.01%	1104
2022 Q2	$501K	Hold	50,200	–	–	﹤0.01%	1019
2022 Q1	$622K	Buy	50,200 +4,600	+10%	+$71.1K	﹤0.01%	1018
2021 Q4	$1.02M	Hold	45,600	–	–	﹤0.01%	933
2021 Q3	$1.04M	Hold	45,600	–	–	﹤0.01%	892
2021 Q2	$586K	Hold	45,600	–	–	﹤0.01%	1038
2021 Q1	$565K	Hold	45,600	–	–	﹤0.01%	1007
2020 Q4	$623K	Buy	45,600 +8,700	+24%	+$127K	﹤0.01%	978
2020 Q3	$518K	Buy	+36,900	New	+$535K	﹤0.01%	924

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AUPH Position: Q2 2025 in Review

DekaBank Deutsche Girozentrale sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 7,480 shares — an estimated $60K sold.

DekaBank Deutsche Girozentrale first reported a position in AUPH in Q3 2020 and held it in 13 quarters. The position peaked at $1.04M in Q3 2021. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

DekaBank Deutsche Girozentrale reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 7,480 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $60K.
DekaBank Deutsche Girozentrale first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 13 quarters.
DekaBank Deutsche Girozentrale's Aurinia Pharmaceuticals position peaked at $1.04M in Q3 2021.
219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2025, filed 30 Jul 2025.